Global High-Priority Regulatory Events — March 19, 2026

19-03-2026

The Gabelli Global Utility & Income Trust has filed a definitive proxy statement for its Annual Meeting of Shareholders on May 11, 2026, at 10:00 a.m. ET, to elect two Trustees: Salvatore J. Zizza by common and preferred shareholders voting together as a single class, and Leslie F. Foley by preferred shareholders as a separate class. The record date is March 12, 2026, with 5,990,356 Common Shares, 10,977 Series A Preferred Shares, and 484,590 Series B Preferred Shares outstanding; no dividend arrearages exist on Preferred Shares. GAMCO Investors, Inc. and affiliates beneficially own 9.5% of Common Shares.

• ·Quorum requires holders of one-third of outstanding shares entitled to vote; separate one-third quorum for Preferred Shares Trustee election.
• ·Board divided into three classes with staggered three-year terms; all nine Trustees are independent (non-interested persons).
• ·No dividend arrearages on Preferred Shares; Preferred holders entitled to elect majority of Trustees if arrears persist for two years.
• ·Proxy materials mailing begins on or about April 1, 2026; fiscal year ended December 31, 2025.

19-03-2026

Mount Logan Capital Inc. (MLCI) announced that its managed Opportunistic Credit Interval Fund (SOFIX) entered a definitive agreement to acquire over $100 million in assets from Yieldstreet Alternative Income Fund (YS AIF), nearly doubling SOFIX's size and expected to boost MLCI's annual fee-related earnings (FRE) by at least $2.8 million, or more than 30% of trailing twelve-month FRE as of December 31, 2025. The transaction, including a Transition Services Agreement (TSA) with Willow Wealth, is projected to be immediately accretive to FRE upon closing in late Q2 or Q3 2026, subject to regulatory and YS AIF shareholder approvals. MLCI had over $2.1 billion in assets under management as of December 31, 2025.

• ·YS AIF suspended share offerings effective immediately, but automatic dividend reinvestment plan continues.
• ·Transaction unanimously approved by SOFIX Board of Trustees and YS AIF Board of Directors.
• ·Intended as tax-free reorganization for YS AIF shareholders; no SOFIX shareholder vote required.
• ·TSA stock subject to lock-up provisions.

19-03-2026

The National Company Law Tribunal (NCLT) Chennai Bench approved the Resolution Plan submitted by Successful Resolution Applicant Guruswamy Ramamurthy for Rajeswari Infrastructure Limited on January 13, 2026, concluding the Corporate Insolvency Resolution Process (CIRP) initiated via petition by Intec Capital Limited and admitted on May 10, 2023. The plan received CoC approval with 84.37% voting share after multiple revisions, extensions, and abstentions (e.g., Religare Finvest Limited at 68.91% initially abstained). The order disposes of related applications, including one seeking recovery of ₹2.19 Cr from respondent Guruswamy Ramamurthy.

• ·CIRP petition CP(IB)/133(CHE)/2022 admitted on May 10, 2023; public announcement on May 17, 2023 with claims deadline May 25, 2023
• ·Multiple CoC extensions approved: 90 days (Jan 19, 2024), further 90 days (May 9, 2024), 60 days (Sep 9, 2024), further 60 days (Oct 8, 2024), additional 60 days (Dec 16, 2024), and 30 days (Jan 2025)
• ·Resolution Plan e-voting extended from Nov 11, 2024 to Dec 25, 2024 at request of Union Bank of India
• ·CoC reconstituted after claim from Religare Finvest Limited (Aug 18, 2023 order)
• ·Addendum to Resolution Plan approved by CoC with 100% voting on Aug 25, 2025 proceedings

19-03-2026

19-03-2026

ITC Limited announced that its members have approved via postal ballot through e-voting the appointment of Mr. Navin Agarwal (DIN: 10684167) as a Non-Executive Director, liable to retire by rotation, for a period of three years effective from April 1, 2026. Mr. Agarwal, aged 55 and representing the Specified Undertaking of the Unit Trust of India (SUUTI), brings nearly three decades of experience in public finance, capital markets, and public sector governance. He currently serves as Joint Secretary in the Department of Investment and Public Asset Management, Ministry of Finance, Government of India, and has confirmed no debarment from holding directorship.

• ·Appointment follows letters dated January 29, 2026, and February 12, 2026.
• ·Education: Bachelors in Economics (Delhi University), Masters in Climate Change, Management & Finance (Imperial Business School, London), Master of Public Administration in Finance and Fiscal Policy (Cornell University, USA).
• ·Joined Indian Railway Personnel Service in 1997; prior roles include Director in Department of Economic Affairs and Executive Director on Railway Board.
• ·No relationships with other directors.
• ·Compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and SEBI Master Circular dated January 30, 2026.

19-03-2026

Aclarion, Inc. announced that its Board unanimously adopted a limited duration stockholder rights plan, effective immediately and expiring in one year on March 18, 2027, to protect shareholder value by deterring unapproved acquisitions of 10% or more of common stock without a control premium. Rights will distribute as a dividend on March 30, 2026, for each share of common stock and Rights-Eligible Warrants, becoming exercisable upon triggering events to allow holders (excluding the acquirer) to purchase preferred stock equivalent to twice the $14.00 exercise price in common stock value. The plan applies equally to all stockholders, grandfathering existing >10% owners from triggering if they do not increase holdings, and was not adopted in response to any specific takeover threat.

• ·Rights attach to each share of Common Stock (par value $0.00001) and Rights-Eligible Warrants as of Record Date March 30, 2026
• ·Board may redeem rights at $0.001 per right or exchange for one share of Common Stock per right
• ·No dead-hand, slow-hand, or similar features limiting future Board actions
• ·Aclarion leverages MRS, biomarkers, and AI for chronic low back pain via Nociscan SaaS platform

19-03-2026

On March 19, 2026, the Boards of Directors of Mercantile Bank Corporation and its subsidiary Mercantile Bank adopted the 2026 Executive Officer Bonus Plan, establishing a target bonus pool of $1.21M scalable up to a maximum of $1.81M based on performance against six metrics: earnings per share (25-37.5% weight), return on assets (25-37.5%), net interest margin (12.5-18.75%), efficiency ratio (12.5-18.75%), non-performing assets (12.5-18.75%), and loans-to-deposits (12.5-18.75%). The plan covers six executives including CEO Raymond E. Reitsma, with maximum payouts as a percentage of 2026 salary ranging from 52.5% for the Chief HR Officer to 90% for the CEO. Bonuses, if earned, will be paid pro rata on or before March 15, 2027, subject to clawback provisions.

• ·Bonus pool allocation uses linear interpolation between target and maximum performance levels for each metric.
• ·Each metric must meet target level to contribute its percentage to the bonus pool; example calculations provided for partial achievement.
• ·Adjustments to maximum bonus pool for new hires, salary changes, or ineligibility before December 31, 2026.
• ·Plan may be amended by Compensation Committee and includes clawback provisions.

19-03-2026

Halder Venture Limited disclosed that BSE imposed a fine of ₹5,42,800 including GST for non-compliance with Regulation 17(1) on Board of Directors composition for the quarter ended September 2025, with the original notice dated November 28, 2025. The company's waiver application submitted on December 1, 2025, was rejected via email on March 18, 2026. The impact is nil except for the fine amount, with no broader financial or operational effects.

• ·Fine reference: SOP-C Review/QTR-September 2025
• ·Rejection email received on March 18, 2026 at 4:41 PM

19-03-2026

Promoters of Embassy Developments Limited, namely Embassy Property Developments Private Limited (Promoter Group) and JV Holding Private Limited (Promoter), have disclosed encumbrance (pledge) of 29,65,40,930 equity shares, representing 49.996% of their total 59,31,29,123 shareholding (42.6517% of total share capital) or 21.3242% of the company's total share capital. The pledges secure unlisted, unrated non-convertible debentures totaling ₹1,077.5 Cr issued by Serenesummit Realty Private Limited (₹577.5 Cr) and JV Holding Private Limited (₹500 Cr), with security covers of 0.46x and 3.22x based on share values of ₹267.66 Cr and ₹1,611.94 Cr respectively. Proceeds are for promoter group refinancing of existing facilities, working capital, and general corporate purposes.

• ·Pledges created in favor of Catalyst Trusteeship Limited, a trusteeship services provider (not a bank/NBFC).
• ·Debentures are unrated, unlisted, and redeemable with face value ₹10 lakh each.
• ·Funds not to be used for purposes prohibited by applicable laws.

19-03-2026

The Reserve Bank of India (RBI) approved a transition arrangement for the Part Time Chairman position at HDFC Bank Limited, as requested by the bank. RBI described HDFC Bank, a Domestic Systemically Important Bank (D-SIB), as having sound financials, a professionally run board, competent management, no material concerns on conduct or governance, remaining well-capitalized with a satisfactory financial position and sufficient liquidity. RBI stated it will continue to engage with the bank's Board and management on the way forward.

19-03-2026

Bharat Coking Coal Limited achieved a record single-day coal booking of approximately 2,36,850 tonnes under its Special Discount Scheme offering discounts from ₹100 to ₹600 per tonne. Bookings included 1,80,000 tonnes via rail mode across 45 rakes and 56,850 tonnes via road mode, reflecting strong consumer response. This milestone underscores the effectiveness of the company's consumer-centric policies, expected to support steel and core industries.

• ·E-auction conducted on March 18, 2026
• ·Scrip Code: 544678
• ·ISIN: INE05XR01022
• ·Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

19-03-2026

Deep Industries Limited informed stock exchanges on March 19, 2026, of an amendment to a prior provisional suspension of business dealings (dated February 13, 2026), revoking the suspension specifically for Gas Compression services, Gas Dehydration Services, Hiring Services of GCP plus GDU, Hiring Services of DPDU, Hiring of 1000 HP Drilling Rig services, and Hiring of onshore Rigs of 100 MT. However, the provisional suspension remains in effect for other specified contracts. The company asserts the suspension is unwarranted and expects a favorable resolution.

• ·Scrip Code: 543288
• ·Symbol: DEEPINDS
• ·Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

19-03-2026

ICICI Prudential Life Insurance Company Limited issued a clarification on a Business Standard news article dated March 19, 2026, titled 'Prudential may exit life insurance joint venture with ICICI Bank', stating the company is unaware of any such developments. Prudential Corporation Holdings Limited responded that it does not comment on market rumours or speculations. The company reaffirmed its commitment to regulatory compliance and prompt disclosure of material information.

• ·Scrip Codes: Equity (BSE: 540133/NSE: ICICIPRULI); Debt (NSE: ICPR34, ICPR35)
• ·CIN: L66010MH2000PLC127837

19-03-2026

FreightCar America, Inc. (RAIL) filed a DEF 14A proxy statement for its virtual Annual Meeting of Stockholders on April 10, 2026, at 10:00 a.m. Central Time, to elect three Class III directors for three-year terms, approve on an advisory basis the compensation of Named Executive Officers, and ratify Grant Thornton LLP as independent registered public accounting firm for fiscal year 2026. The record date is February 10, 2026, with 19,062,155 shares of common stock outstanding entitled to vote. Proxy materials are being mailed on or about March 19, 2026.

• ·Meeting held virtually only via live webcast at www.meetnow.global/MFVJ6LW
• ·Voting requires 15-digit control number for proxy submission via internet, phone, or mail
• ·Quorum requires majority of shares outstanding on record date present virtually or by proxy

19-03-2026

DarioHealth Corp. reported total revenues of $22.4M for FY 2025, down 17% YoY from $27.0M, driven by a 26% decline in services to $14.9M despite an 8.5% increase in consumer hardware to $7.4M. Operating expenses fell 31% to $49.3M, resulting in a smaller operating loss of $36.7M versus $57.7M prior year, and net loss improved slightly to $41.7M from $42.7M; however, cash and equivalents dropped to $21.8M from $27.8M, total assets declined to $110.1M from $118.9M, and stockholders' equity decreased to $67.9M from $72.0M amid significant share dilution to 6.9M shares outstanding.

• ·Cash used in operating activities improved to $(25.9M) from $(38.6M) YoY.
• ·Non-GAAP adjusted loss improved to $(24.2M) from $(33.8M), a $9.6M betterment.
• ·Accumulated deficit worsened to $(452.1M) from $(390.3M).
• ·Basic and diluted loss per share improved to $10.12 from $12.27.
• ·Weighted average shares increased to 3,983K from 2,452K.

19-03-2026

RYVYL Inc. adjourned its Special Meeting of Shareholders on March 18, 2026, to vote on the planned merger with RTB Digital, Inc. (Roundtable), reconvening virtually on March 25, 2026, at 4pm EST. Approximately 99% of votes cast supported the merger, with 43% of entitled shares voted, requiring only an additional 7% in favor to approve; however, the adjournment highlights that quorum or majority threshold has not yet been met. The company urges unvoted shareholders to participate promptly via Kingsdale Advisors.

• ·Record date for Special Meeting: February 6, 2026 (unchanged)
• ·Virtual meeting link: http://www.virtualshareholdermeeting.com/RVYL2026SM
• ·Voting assistance contact: Kingsdale Advisors at 888-518-6812 or contactus@kingsdaleadvisors.com

19-03-2026

AMERICAN VANGUARD CORPORATION (as Holdings) and AMVAC CHEMICAL CORPORATION (as Borrower) entered into a Credit and Guaranty Agreement dated March 13, 2026, with Wilmington Trust, National Association as Administrative Agent and certain lenders, establishing a senior secured term loan facility with an aggregate principal amount of $225 million. The facility provides financing subject to covenants, representations, and events of default, with interest rates starting at Term SOFR plus 8.25% or Base Rate plus 7.25%, eligible to step down based on improvements in the Consolidated Total Leverage Ratio below thresholds like 4.00:1.00. No prior period financial performance data or comparisons are disclosed in the filing.

• ·Compliance Certificate due two business days after quarterly financials for fiscal quarter ending June 30, 2026, to potentially adjust Applicable Margin.
• ·ABL Facility permitted if approved by Required Lenders, secured junior to term loan on non-ABL Priority Collateral.

19-03-2026

Brunswick Corporation's 2026 Proxy Statement seeks shareholder approval for the election of 10 directors (9 independent, 99% board attendance in 2025, median tenure 9.9 years), an advisory vote on 2025 Named Executive Officer compensation (with 97% Say-on-Pay approval in 2025), and ratification of the independent auditor for FY2026. CEO David M. Foulkes received $13.0M total 2025 compensation, predominantly at-risk through stock awards ($9.8M) and annual bonus ($1.9M), while other NEOs averaged ~$2.8M. The proxy highlights strong governance with no hedging/pledging, clawbacks, and double-trigger change-in-control provisions, though median director tenure reflects some longevity.

• ·Median director tenure: 9.9 years
• ·Annual meeting date: May 6, 2026 at 8:00 a.m. EDT (virtual at www.virtualshareholdermeeting.com/BC2026)
• ·Form 10-K filed February 13, 2026 for FY ended December 31, 2025
• ·Proxy materials notice mailed starting March 19, 2026

19-03-2026

SAB Biotherapeutics, Inc. (Nasdaq: SABS) announced on March 17, 2026, a proposed underwritten public offering of common stock and pre-funded warrants, with underwriters granted a 30-day option to purchase up to an additional 15% of the securities. Net proceeds, along with existing cash, will primarily fund the development of clinical-stage candidate SAB-142 through ongoing and planned trials, manufacturing, regulatory activities, and general corporate purposes. The offering is subject to market conditions with no assurance of completion or final terms.

• ·Shelf registration statement on Form S-3 (No. 333-292482) filed December 29, 2025, declared effective January 7, 2026.
• ·Joint book-running managers: Jefferies, UBS Investment Bank, Citigroup, Barclays; lead manager: Chardan.

19-03-2026

Selectis Health, Inc. appointed Richard Huebner, age 68, as a new member of its Board of Directors effective March 12, 2026. Mr. Huebner, senior managing partner at GVC Capital LLC since 2001, has extensive experience in investment banking, compliance, and legal roles at firms including Fiserv Correspondent Services and Hanifen Imhoff Inc. He will receive an annual stipend of $30,000 under the company's Outside Directors Compensation Plan.

• ·Richard Huebner served as registered investment advisor (2000-2001), Executive Vice President at Fiserv Correspondent Services (1984-2000), and various roles at Hanifen Imhoff entities (1979-1997) and First Mid America, Inc. (1980-1983).
• ·Education: Bachelor’s degree from Hastings College (1979); Juris Doctorate from University of Nebraska (1982).

19-03-2026

On March 17, 2026, The Cannabist Company Holdings Inc. secured a further extension of a forbearance agreement from an ad hoc group of noteholders for its 9.25% Senior Secured Notes due December 31, 2028, and 9.00% Senior Secured Convertible Notes due December 31, 2028, postponing any exercise of remedies until March 25, 2026. This development signals ongoing financial stress and potential covenant issues under the amended indenture. No financial metrics or performance data were disclosed.

• ·Registrant is an emerging growth company.
• ·Principal executive offices: 321 Billerica Road, Chelmsford, Massachusetts 01824.
• ·Telephone: (978) 910-1486.
• ·No securities registered pursuant to Section 12(b) of the Act.

19-03-2026

argenx SE reported robust 2025 financial results with product net sales surging 90% YoY to $4.15B from $2.19B, driving total operating income up 89% to $4.25B and flipping operating profit to $1.05B from a $22M loss. However, total operating expenses increased 40% to $3.19B due to cost of sales rising 98% to $451M, R&D up 39% to $1.36B, and SG&A up 30% to $1.37B; profit grew 55% to $1.29B but the income tax benefit dropped 98% to $13M. Basic EPS rose 51% to $21.08.

• ·2025 Remuneration Policy approved at approx. 96% vs 2021 policy at 77%.
• ·Non-Executive Director annual equity grant: $400,000 in restricted shares with 4-year holding.
• ·Shares outstanding grew from 59,194,488 (Dec 31, 2023) to 61,883,306 (Dec 31, 2025).

19-03-2026

Republic Airways Holdings Inc. reported FY2025 revenues of $1,676.5M, up 13.7% YoY from $1,474.0M, with operating income rising 22.8% to $168.3M and Adjusted EBITDA surging 32.9% to $341.7M, driving net income to $76.2M (+18.0%). However, executive separation and merger-related costs jumped to $47.1M from $3.2M, total liquidity declined 1.1% to $319.9M, and net cash used in investing activities ballooned to $350.9M. In FY2024 vs FY2023, revenues grew modestly 3.1% but Adjusted EBITDA fell 12.8% to $257.2M.

• ·Net cash provided by operating activities increased 42.4% to $322.0M in FY2025 from $226.1M.
• ·Net cash used in investing activities worsened to $350.9M in FY2025 from $105.5M.
• ·Income tax expense rose 66.8% to $37.2M in FY2025.
• ·Depreciation and amortization increased 7.9% to $126.3M in FY2025.
• ·Marketable securities declined 15.3% to $162.2M in FY2025.

19-03-2026

Artius II Acquisition Inc., a SPAC, reported net income of $136k for the year ended December 31, 2025, compared to a $85k net loss for the period from inception (July 25, 2024) through December 31, 2024, driven by $8.1M interest income from the Trust Account offsetting a $7.9M operating loss that included a $6M advisory fee. Total assets grew to $228.3M primarily from $228.1M in the Trust Account following the IPO of 22M Class A shares, but shareholders' deficit widened significantly to $13.8M due to accretion of $18.8M. Cash position was minimal at $32k.

• ·IPO involved sale of public units generating $219.75M net proceeds.
• ·Founder shares: 250,000 Class B shares forfeited by Sponsor.
• ·Promissory note to related party repaid $135k in 2025.
• ·Basic and diluted EPS of $0.01 for redeemable and non-redeemable Class A shares in 2025.
• ·Class B shares EPS not applicable in 2025; prior period loss per share ($0.02).

19-03-2026

Rice Acquisition Corp 3, a SPAC, reported net income of $2.85M for the period from inception (June 6, 2025) to December 31, 2025, driven by $3.4M interest income from the Trust Account offsetting a $548K operating loss from formation and administrative costs. Total assets stood at $351.3M, primarily $348.4M cash in the Trust Account from IPO proceeds (34.5M Class A shares at $10.10 redemption value), while shareholders' deficit was $13.2M due to accretion and transaction costs. No business combination has occurred, with cash outside trust at $2.6M and ongoing liabilities including $13.4M deferred underwriting fees.

• ·IPO-related financing: $338.1M proceeds from Units net of underwriting discounts; $10.65M from Private Placement Warrants
• ·Cash flows: Net used in operations $(467.5K); investing $(345M) into Trust; financing $348.1M
• ·Non-cash: Accretion of Class A shares to redemption $28.9M; transaction costs allocated $257K

19-03-2026

Micron Technology reported exceptional Q2 FY2026 results with revenue surging 196% YoY to $23.9B from $8.1B, gross margin expanding dramatically to $17.8B (499% YoY increase), and net income skyrocketing 771% YoY to $13.8B. For the six months ended February 26, 2026, revenue more than doubled 124% YoY to $37.5B with net income up 451% to $19.0B. The balance sheet strengthened significantly, with cash and equivalents rising 44% to $13.9B, total assets up 23% to $101.5B, and long-term debt reduced 32% to $9.6B, though inventories dipped slightly 1% QoQ.

• ·EPS diluted Q2 FY2026: $12.07 (vs $1.41 YoY, +756%)
• ·R&D expense Q2: $1.25B (up 39% YoY)
• ·Stock-based compensation expense six months: $599M
• ·Dividends declared Q2: $0.115 per share ($132M total); six months $0.23 per share ($264M total)
• ·Several senior notes repaid in period including 2028 Notes, 2029 A/B Notes, 2029 Term Loan A, 2030 Notes (October 2025/February 2026)

19-03-2026

Lithium Americas Corp. (LAC) reported a widened net loss of $86.3M for the year ended December 31, 2025, compared to $42.6M in 2024, with net loss attributable to stockholders rising to $122.1M from $42.5M, driven by higher G&A expenses ($52.8M vs. $28.1M, +88%) and transaction costs ($32.3M vs. $22.2M, +45%), despite a $160M gain on warrant obligations offset by a $171M loss on convertible debt. Balance sheet growth was robust with cash and restricted cash up 52% to $905.6M, total assets more than doubling to $2.58B from $1.04B, and mineral properties, plant & equipment surging to $1.34B from $399M amid $765M investing outflows. However, total liabilities ballooned nearly 10-fold to $992.4M from $99.6M due to new DOE loan ($351M), convertible debt ($160M), and warrant obligations.

• ·Net cash provided by financing activities: $1,137.6M in 2025 vs. $589.1M in 2024 (+93%).
• ·Proceeds from public offerings: $401.2M in 2025.
• ·Proceeds from non-controlling interest: $100M in 2025 (Lithium Nevada Ventures LLC).
• ·Non-controlling interest increased to $527.9M from $310.3M.
• ·Weighted average shares outstanding: 243,658 (2025) vs. 200,817 (2024).

19-03-2026

Larsen & Toubro Limited (L&T) received Observation Letters from BSE Limited (dated 18 March 2026) and National Stock Exchange of India Limited (NSE, dated 19 March 2026) providing 'No Objection' for the proposed Scheme of Arrangement involving the slump sale of L&T's realty undertaking to L&T Realty Properties Limited (LTRPL), following board approval on 08 December 2025. The letters outline extensive compliance conditions, including disclosures on financials, valuations, risks, ongoing proceedings, and shareholder impacts, with the scheme valid for NCLT filing within six months from 19 March 2026. No financial metrics or changes are disclosed in this intimation.

• ·Observation Letters issued under Regulation 37 of SEBI (LODR) Regulations, 2015.
• ·Scheme to be filed with NCLT within 6 months from 19 March 2026.
• ·Company must disclose additional details like latest financials (not older than 6 months), pre/post scheme shareholding, revenue/PAT/EBITDA for last 3 years, and impact on reserves/securities premium.